®
Scale Up Commercial Manufacture List
| Chemical Structure | Cat. No. | CAS. No. | Formula | M.W |
|---|
 |
BD110066 | 642494-37-9 | C14H18BNO2 | 243.11 |
| 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | ||||
![5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole](https://file.bldpharm.com/static/upload/proimg/98/1073354-91-2.png) |
BD229279 | 1073354-91-2 | C13H16BNO2S | 261.15 |
| 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole | ||||
 |
BD210704 | 212127-83-8 | C15H26BNO4 | 295.18 |
| tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate | ||||
 |
BD218087 | 1218790-88-5 | C8H11BO3 | 165.98 |
| (4-(Hydroxymethyl)-3-methylphenyl)boronic acid | ||||
 |
BD231250 | 90111-58-3 | C8H9BO4 | 179.97 |
| 2-(4-Boronophenyl)acetic acid | ||||
 |
BD160299 | 886536-37-4 | C8H8BF3O3 | 219.95 |
| (4-(2,2,2-Trifluoroethoxy)phenyl)boronic acid | ||||
 |
BD165599 | 864754-18-7 | C15H26BN3O3 | 307.20 |
| 4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethyl)morpholine | ||||
 |
BD223380 | 1052686-67-5 | C11H17BN2O2 | 220.08 |
| 2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | ||||
 |
BD211291 | 1002309-48-9 | C13H21BN2O2 | 248.13 |
| 1-Cyclobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ||||
![1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine](https://file.bldpharm.com/static/upload/proimg/148/886547-94-0.png) |
BD159616 | 886547-94-0 | C19H21BN2O4S | 384.26 |
| 1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine | ||||